Christopher Dinsmore

Christopher Dinsmore

Corporate Officer/Principal at Stablix, Inc.

Net worth: 339 260 $ as of 2024-03-30

58 year
Health Technology
Consumer Services
Commercial Services

Profile

Christopher Dinsmore's current jobs include Advisor at Wisconsin Alumni Research Foundation and Scientific Advisory at Stablix, Inc. Formerly, Dr. Dinsmore worked as Executive Director-Discovery Chemistry at Merck & Co., Inc. He also served as VP-Medicinal & Computational Chemistry at FORMA Therapeutics, Inc. from 2014 to 2019.
In 2019, he was an Entrepreneur-Residence at Third Rock Ventures LLC.
From 2020 to 2024, he held the position of Chief Scientific Officer at Kronos Bio, Inc.Dr. Dinsmore completed his undergraduate degree at Bowdoin College and obtained a doctorate from the University of Minnesota.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-03 260,969 ( 0.43% ) 339 260 $ 2024-03-30

Christopher Dinsmore active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
All active positions of Christopher Dinsmore

Former positions of Christopher Dinsmore

CompaniesPositionEnd
KRONOS BIO, INC. Chief Tech/Sci/R&D Officer 2024-02-15
Corporate Officer/Principal 2020-06-01
Corporate Officer/Principal 2019-05-31
MERCK & CO., INC. Corporate Officer/Principal -
See the detail of Christopher Dinsmore's experience

Training of Christopher Dinsmore

Bowdoin College Undergraduate Degree
University of Minnesota Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Dinsmore's experience

Connections

81

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MERCK & CO., INC.

Health Technology

KRONOS BIO, INC.

Health Technology

Private companies4

Health Technology

Commercial Services

Commercial Services

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Dinsmore